Novago Therapeutics
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury
About Novago Therapeutics
NovaGo Therapeutics AG is a Zurich-based biotechnology startup focused on developing novel human antibody therapeutics to support recovery from cerebral stroke and spinal cord injuries. Founded in 2015, the company aims to stimulate nerve repair and regeneration through innovative, science-driven approaches, addressing significant unmet medical needs in neuroregeneration. By advancing cutting-edge antibody therapies, NovaGo Therapeutics seeks to improve patient outcomes and restore neurological function after severe injuries.
Recently Added Startups
Novago Therapeutics
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury
Boomerang
Boomerang brings sustainability to e-commerce by replacing single-use shipping packages with reusable ones. Its intelligent deposit and return logistics system enables packaging to be reused up to 50 times, reducing waste.
Pristem
Pristem SA is a Swiss medical company providing equitable, sustainable access to affordable, high-quality diagnostics. The firm focuses on expanding global access to radiology through innovative medical equipment solutions.
Related Post
Top 10 HealthTech Startups in Denmark
London-based Merx Raises €1.1Mn To Connect Brands With Consumers Via WhatsApp
VectorTree Gets EU Funding to Build Advanced AI Database
Biotech
Novago Therapeutics
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury
Cocoon Bioscience
Cocoon Bioscience develops high-value enzymes and recombinant proteins using an automated platform that leverages cocooned insects as natural, low-cost bioreactors, providing efficient, sustainable, and scalable solutions for biotechnology applications.
Switzerland
Novago Therapeutics
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury
Oculis
Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) dedicated to saving sight and advancing eye care, developing innovative therapies to address unmet needs in ophthalmology worldwide.